Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

LEO-43204 is effective for treating actinic keratosis on the face and chest

Oct. 29, 2015

Tofacitinib is beneficial in treating atopic dermatitis in phase IIa study

Oct. 23, 2015

OPA-15406 shows promise in phase II atopic dermatitis trial

Oct. 22, 2015

Foamix initiates phase II trial of FMX-103 in papulopustular rosacea

Oct. 22, 2015

RXi Pharmaceuticals reports interim data from phase IIa study of RXI-109

Oct. 19, 2015

Izun Pharmaceuticals reports data from phase II trial in diabetic foot ulcers

Oct. 15, 2015

Sebacia completes enrollment in trial of acne treatment

Oct. 13, 2015

Boehringer Ingelheim reports phase II data for BI-655066 in psoriasis

Oct. 9, 2015

Osiris begins phase III trial of OTI-15-01 in chronic diabetic foot wounds

Oct. 8, 2015

BARDA awards contract to Stratatech for StrataGraft skin substitute

Oct. 7, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...